![Jigar Raythatha](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jigar Raythatha
Directeur/Bestuurslid bij
Flare Therapeutics, Inc.
Profiel
Jigar Raythatha is currently Director at TRIANA Biomedicines, Inc., Director at Flare Therapeutics, Inc. since 2023, and Partner at Third Rock Ventures LLC since 2021.
Former positions include President, Chief Executive Officer & Director at Constellation Pharmaceuticals, Inc. from 2017 to 2021; Chairman at Jounce Therapeutics, Inc. from 2022 to 2023; Chief Business Officer at Jounce Therapeutics, Inc. from 2012 to 2017; Principal at Biogen MA, Inc., Pfizer Inc., Shire Regenerative Medicine, Inc., and Red Abbey Venture Partners LLC from 2005 to 2009; and Board Member at American Cancer Society, New England Division, Inc. Education includes an MBA from Columbia Business School and The Trustees of Columbia University in The City of New York, and an undergraduate degree from Rutgers State University of New Jersey conferred in 1998.
Actieve functies van Jigar Raythatha
| Bedrijven | Functie | Begin |
|---|---|---|
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm focuses on the healthcare. It participates in early stage capital requirements. The firm also acts as lead investor. | Private Equity Investor | 01-01-2021 |
Santi Therapeutics, Inc.
 Santi Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics to treat diseases | Directeur/Bestuurslid | - |
Flare Therapeutics, Inc.
 Flare Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of small molecule medicines | Directeur/Bestuurslid | 30-03-2023 |
Eerdere bekende functies van Jigar Raythatha
| Bedrijven | Functie | Einde |
|---|---|---|
| JOUNCE THERAPEUTICS, INC. | Voorzitter | 03-05-2023 |
| CONSTELLATION PHARMACEUTICALS, INC. | Algemeen Directeur | 15-07-2021 |
| JOUNCE THERAPEUTICS, INC. | Corporate Officer/Principal | 01-02-2017 |
American Cancer Society, New England Division, Inc. | Directeur/Bestuurslid | - |
| PFIZER INC. | Corporate Officer/Principal | - |
Opleiding van Jigar Raythatha
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
66
Eerstegraads connecties
13
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 13 |
|---|---|
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Develops and manufactures drugs related to immunology, neurobiology and oncology | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Shire Regenerative Medicine, Inc.
 Shire Regenerative Medicine, Inc. BiotechnologyHealth Technology Manufactures biomedical products | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Red Abbey Venture Partners LLC
 Red Abbey Venture Partners LLC Investment ManagersFinance Red Abbey Venture Partners invests in companies located in North America and Europe. The firm focuses on a broad range of sectors. It participates in early and late-stage transactions. It acts as a co-investor and invests in public companies. | Finance |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm focuses on the healthcare. It participates in early stage capital requirements. The firm also acts as lead investor. | Finance |
Constellation Pharmaceuticals, Inc.
 Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs targeting regulators of epigenetic function | Health Technology |
American Cancer Society, New England Division, Inc. | |
Jounce Therapeutics, Inc.
 Jounce Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immunotherapy company that develops therapies to treat cancer | Health Technology |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Santi Therapeutics, Inc.
Santi Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics to treat diseases | Health Technology |
Flare Therapeutics, Inc.
Flare Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of small molecule medicines | Health Technology |
Kies MarketScreener 
